Fresh2 Group Limited (NASDAQ:FRES – Get Free Report) saw a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 11,900 shares, an increase of 83.1% from the October 31st total of 6,500 shares. Based on an average daily trading volume, of 44,400 shares, the days-to-cover ratio is currently 0.3 days.
Analysts Set New Price Targets
Separately, Canaccord Genuity Group upgraded shares of Fresh2 Group to a “strong-buy” rating in a research note on Thursday, August 8th.
Read Our Latest Report on FRES
Fresh2 Group Stock Up 22.6 %
About Fresh2 Group
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People’s Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc.
Featured Articles
- Five stocks we like better than Fresh2 Group
- What Are Dividend Contenders? Investing in Dividend Contenders
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What to Know About Investing in Penny Stocks
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Fresh2 Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh2 Group and related companies with MarketBeat.com's FREE daily email newsletter.